πŸ‡ΊπŸ‡Έ FDA
Patent

US 10975365

Di-enzymatic chimeric endolysin

granted A61KA61K38/00

Quick answer

US patent 10975365 (Di-enzymatic chimeric endolysin) held by Government of the United States of America, as represented by the Secretary of Commerce expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Government of the United States of America, as represented by the Secretary of Commerce
Grant date
Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00